To help assure the draft guideline’s integrity and credibility, CDC then began a multistep review process to obtain input from experts, stakeholders, and the public to help refine the recommendations. When it comes to the possibility of developing tolerance to pregabalin and gabapentin, studies show that gabapentinoids usually do not cause the same quick development of tolerance as direct agonists like opioids (51). This trait is especially important for treating chronic pain, as long-term pharmaceutical effectiveness is critical for patient outcomes. The analgesic effects of pregabalin and gabapentin are facilitated by their modes of action, which involve binding to the α2δ subunit of voltage-activated calcium channels.
60-MPH Times
- In addition, pregabalin has been shown to cross the placenta in rats and is present in the milk of lactating rats.
- The clinical trial data on Tonmya shows it relieved several fibromyalgia symptoms during the 14-week study.2 Based on 457 patients (half taking a placebo), the sublingual reduces pain, sleep disruption, fatigue, cognitive impairments (fibrofog), and sexual dysfunction.
- Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist.
- Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
- Do not take other medicines unless they have been discussed with your doctor.
Overall, pregabalin is considered to have a better balance between cost and effectiveness (28). Other studies have also demonstrated that both generic and branded forms of generic lyrica cost pregabalin are highly cost-effective compared to placebo (27). Therefore, including generic pregabalin in the reimbursement list would be a more rational option, considering its similar efficacy to the branded version but at a lower cost (27). However, it is important to consider the limitations in the number of available studies to evaluate the influence of dosage on cost-effectiveness relationship. From the perspective of the Spanish healthcare system, it has been concluded that pregabalin is more cost-effective than gabapentin in the majority of studied cases, implying additional health benefits and a positive impact on patients’ work capacity (32). Findings from the contextual reviews provide indirect evidence and should be interpreted accordingly.
Assessing Risk and Addressing Harms of Opioid Use
Conditions such as neuropathic pain, epilepsy, and anxiety disorders have become more common as the world’s older population is increasing, thus boosting the adoption of pregabalin, thereby giving pregabalin market opportunity to key players for market expansion. The global pregabalin market size was valued at $1.6 billion in 2022, and is projected to reach $2.2 billion by 2032, growing at a CAGR of 3% from 2023 to 2032. According to the World Health Organization (WHO), epilepsy affects over 50 million individuals worldwide, making it one of the most prevalent neurological conditions. It is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. However, in low-income countries, about three-quarters of people with epilepsy do not receive the necessary therapy; in certain economies, this number reaches 90%.
